✦ LIBER ✦

Advances in diagnosis and treatment in patients with pulmonary arterial hypertension

✍ Scribed by Myung H. Park

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 108 KB
Volume: 71
Category: Article
ISSN: 1522-1946
DOI: 10.1002/ccd.21389

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Advancements in diagnosis of pulmonary a

Advancements in diagnosis of pulmonary arterial hypertension in scleroderma

✍ Virginia Steen 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 36 KB

Nifedipine Treatment for Pulmonary Hyper

Nifedipine Treatment for Pulmonary Hypertension in a Patient with Systemic Sclerosis

✍ Stephen Ocken; Elizabeth Reinitz; Joel Strom 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 251 KB 👁 2 views

The etiology of scleroderma remains unknown. However, it is believed that the vascular lesions found in involved organs have a pathogenesis related to endothelial cell injury (1). Pulmonary hypertension is the most common cause of acute dyspnea in patients with systemic sclerosis and is thought to

Pulmonary arteriovenous shunting and pul

Pulmonary arteriovenous shunting and pulmonary artery hypertension in children with liver disease

✍ Olivier Bernard 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 357 KB 👁 1 views

Screening for pulmonary arterial hyperte

Screening for pulmonary arterial hypertension in patients with systemic sclerosis: Clinical characteristics at diagnosis and long-term survival

✍ Marc Humbert; Azzedine Yaici; Pascal de Groote; David Montani; Olivier Sitbon; D 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 2 views

Lung transplantation in scleroderma comp

Lung transplantation in scleroderma compared with idiopathic pulmonary fibrosis and idiopathic pulmonary arterial hypertension

✍ Lionel Schachna; Thomas A. Medsger Jr.; James H. Dauber; Fredrick M. Wigley; Nei 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

## Abstract ## Objective Lung transplantation is a viable, life‐saving intervention for several primary pulmonary disorders complicated by severe lung dysfunction. This study was undertaken to evaluate whether patients with systemic sclerosis (scleroderma), a systemic autoimmune rheumatic disorder

BMPR2 mutation in a patient with pulmona

BMPR2 mutation in a patient with pulmonary arterial hypertension and suspected hereditary hemorrhagic telangiectasia

✍ Christina M. Rigelsky; Constance Jennings; Rainer Lehtonen; Omar A. Minai; Chari 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB

## Abstract Pulmonary arterial hypertension (PAH) and hereditary hemorrhagic telangiectasia (HHT) are distinct clinical entities caused by germline mutations in genes encoding members of the TGFβ/BMP superfamily: __BMPR2__ in PAH and __ACVRL1__, __ENG__, or __SMAD4__ in HHT. When PAH and HHT occasi